Anaesthesia & intensive care medicine
Volume 8, Issue 10 , Pages 427-430, October 2007

Anaesthesia for neurosurgery

Rhys Davies, FRCA, is Specialist Anaesthetic Registrar on the North-west Thames rotation and is and currently working at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He has a special interest in neuroanaesthesia and intensive care

Mary McLoone, FRCA, is locum Consultant Anaesthetist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. She qualified from Charing Cross and Westminster Hospital, and trained in anaesthesia in the North-west Thames region. Her interests include neuroanaesthesia and chronic pain management

Abstract 

Neuroanaesthesia provides its own set of unique challenges. Its aims are to maintain cerebral perfusion and oxygenation, whilst providing optimum operating conditions. Surgery is performed mainly for space-occupying and vascular lesions. The pathology and any pre-existing neurological deficit should be carefully assessed because they influence the conduct of anaesthesia and postoperative care. A balanced anaesthetic technique that maintains haemodynamic stability prevents a harmful elevation in intracranial pressure (ICP) or decreases in cerebral perfusion pressure. To prevent raised ICP, maintenance of PaCO2 between 4.0 and 4.5 kPa, prevention of hypertensive surges, and patient positioning to allow good venous drainage from the head are important. Adequate cerebral perfusion and oxygenation are achieved by preventing hypotension and maintaining PaO2 above 13 kPa. Intraoperative fluid regimes should avoid dextrose-containing solutions, which may exacerbate cerebral ischaemia and lead to cerebral oedema. The choice of crystalloids is contentious, with advocates for both Ringer’s lactate and normal saline. There may be a need to acutely reduce ICP intraoperatively; this can be achieved temporarily with mannitol, furosemide or cautious hyperventilation. Anaesthetic techniques should allow rapid emergence to allow postoperative neurological assessment. Some patients will require close monitoring in a level 2 or 3 ICU. Pain relief is best achieved with a multimodal approach, consisting of local anaesthetic infiltration, regular paracetamol, opioid analgesic agents, and non-steroidal anti-inflammatory agents if appropriate.

Keywords: analgesia, cerebral perfusion, craniotomy, ICP, neuroprotection

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1472-0299(07)00197-X

doi:10.1016/j.mpaic.2007.08.012

Anaesthesia & intensive care medicine
Volume 8, Issue 10 , Pages 427-430, October 2007